U.S. Markets close in 1 hr 42 mins

Hologic downgraded to Neutral from Overweight at Piper Jaffray

Piper Jaffray downgraded Hologic citing a lack of large pipeline deals and competition from Roche. The firm lowered its price target for shares to $21 from $27.